Andrew J. Cowan, MD
Dr. Andrew J. Cowan specializes in multiple myeloma and AL amyloidosis treatment and is involved in clinical trials for plasma cell dyscrasias. He serves as a hematologist-oncologist at Seattle Cancer Care Alliance. Dr. Cowan also serves as an Assistant Professor, University of Washington, Washington, United States.
Dr. Cowan is a graduate from University of Washington School of Medicine, 2008. He did his residency from Boston Medical Center, 2011 and fellowship from University of Washington/Fred Hutchinson Cancer Research Center in Hematology/Oncology, 2015. The year following his residency, Dr. Cowan worked at the Boston University Amyloidosis Center as an amyloid fellow.
Dr. Cowan’s clinical expertise are multiple myeloma, amyloidosis, Waldenström macroglobulinemia, monoclonal gammopathy, smoldering myeloma, plasmacytoma, poems syndrome, plasma cell leukemia and Castleman disease.
Representative Publications:
Antibody-Based Therapy of Acute Myeloid Leukemia With Gemtuzumab Ozogamicin
Management of Acute Myeloid Leukemia in the Intensive Care Setting
Plasma Cell Diseases and Organ Transplant: A Comprehensive Review
Bortezomib and Fenretinide Induce Synergistic Cytotoxicity in Mantle Cell Lymphoma Through Apoptosis, Cell-Cycle Dysregulation, and Iκbα Kinase Downregulation
